poisar

Stocks · News reference

Danaher Could Swing $7.33 Billion in Value After Earnings

Kaustubh Bagalkote

Earnings are back in focus on Tuesday, with a Benzinga-selected slate including Danaher Corp. (NYSE:DHR). Options pricing reveals traders are bracing for volatility, with Annaly Capital Management (NYSE:NLY) and The Charles Schwab Corp. (NYSE:SCHW) reporting. Both stocks have seen positive analyst ratings and are trading above their 200-day moving averages.

More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

DHIDHREQTIBKRMMMNLYSCHW
Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Matt Frankel, Cfp®

    Greg Abel Just Made 3 Moves at Berkshire Hathaway That Bet on the Same Trend (And it's Not AI)

    Berkshire Hathaway CEO Greg Abel is making significant bets on a housing market recovery through multiple moves: acquiring homebuilder Taylor Morrison for $8.5 billion, increasing investment in Lennar by 30%, and buying shares of D.R. Horton. These moves, combined with existing holdings in Clayton Homes and Berkshire Hathaway Home Services, suggest Abel believes pent-up demand will emerge once mortgage rates decline, despite the currently frozen housing market.

    BRK.ABRK.BLENLEN.BDHI
  4. Matthew Benjamin

    Why I'm Wary of Most Housing Stocks, Except This One

    The housing industry faces significant challenges with record home prices ($440,600 median), elevated mortgage rates (6.7%), and a shortage of 4.7 million homes. While traditional homebuilders struggle, manufactured housing company Legacy Housing stands out with impressive Q2 results (32% revenue growth, 59% net income growth) and benefits from recent congressional legislation supporting the sector. The author believes manufactured homes will fill the housing gap due to lower costs (~$120,000) and reduced stigma.

    LEGHPHMDHILENLEN.B
  5. Researchandmarkets.Com

    Global Multiplex Assays Market 2026 Edition - Consumables Dominate Multiplex Assays with 68% Market Share

    The global multiplex assays market is projected to grow from US$6.8 billion in 2025 to US$12.4 billion by 2030, at a 12.8% CAGR. North America leads with 34% market share, while Asia Pacific is the fastest-growing region at 15.5% CAGR. Consumables dominate with 68% market share, and protein multiplex assays hold 42%. Growth is driven by precision medicine, companion diagnostics, and laboratory automation.

    TMOBIOBIO.BQGENTECH
  6. Researchandmarkets.Com

    Lateral Flow Assay Market Size, Industry Dynamics, Opportunity Analysis and Forecast 2026-2035

    The global lateral flow assay market is projected to grow from USD 10.84 billion in 2025 to USD 17.66 billion by 2035, with a 5.0% CAGR. Growth is driven by increased adoption of point-of-care testing, technological innovations including CRISPR-based assays, and the shift toward decentralized diagnostic models. Major players include Abbott, Roche, Siemens Healthineers, and Thermo Fisher Scientific, with infectious disease testing accounting for 72.2% of market share.

    ABTRHHBYTMODHRQDEL